| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7700081 | GALDERMA LABS | Foaming compositions for hair care |
Jan, 2022
(1 year, 8 months ago) | |
Clobex is owned by Galderma Labs.
Clobex contains Clobetasol Propionate.
Clobex has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Clobex are:
- US7700081
Clobex was authorised for market use on 05 February, 2004.
Clobex is available in shampoo;topical dosage forms.
Clobex can be used as topical treatment of scalp psoriasis.
The generics of Clobex are possible to be released after 03 January, 2022.
Drugs and Companies using CLOBETASOL PROPIONATE ingredient
Market Authorisation Date: 05 February, 2004
Treatment: Topical treatment of scalp psoriasis
Dosage: SHAMPOO;TOPICAL
CLOBEX family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic